OpenHAB seeks public feedback on impact of S grade cannabis
Cannabis is a rapidly emerging new legal component of Schedule I of the Controlled Substances Act. The American Medical Associations Cannabis Abuse and Dependence (CADD) is calling on members of the public to send in questions for feedback on the impact on cannabis use and effects on cognition function and life.
Our survey Review of Licensed Clinical Use Guideline Guidelines is aimed at assessing and evaluating public perceptions on various aspects of cannabis law and is also an important tool in preparing policy makers policymakers and law enforcement agencies to effectively combat these statutory and regulatory determinations said the surveys author Dr. Gary Freedman from Wisconsin State University US.
The scientific committee will consider the survey results and will determine how to proceed. However four special interest groups-the national Harm Reduction Centers the Harm Reduction Research Foundation the Coalition for Responsible Consulting and Taxation and Advocacy and the Marijuana Policy Center-will take issue with it.
FUNDING NEEDSSENTENCE Aims underscore: the care and detoxification of cannabis users and experienced users of cannabis including marijuana for medical and pain treatment and to treat chronic pain is still in an emerging stage of in-vivo research from a large sample of well-meaning non-scientific studies to date.
Many of the studies are based on self-reporting and thus dont fabricate or confirm any personal experiences or biases. Also the subjects may come from diverse religious ethnic and socioeconomic backgrounds the study makes no guarantees as to the veracity of the results and the participants can shift their views at any time. Furthermore the study needs to take full account of the fact that much of the randomized clinical research found in marketing material and advertising is based on user expectations and self-reported reports.
In addition the survey draws a line by itself. It does not provide a popular opinion poll of peoples preferences. And questions labeled by Limiting No. 2 must be raised.
OPINION QUESTIONSOverall we would highly recommend the study findings of the review after evaluating the methodological ethical and practical questions surrounding implementing the data collection and analysis. To date this study has generated very few recommendations.
January 2020 APHA Policy Updateon Medical Cannabis and the Second AmendmentCCCommission Memorandum of Public Information Order Request for Regulation of Commercial Sales and Response to the Rohrabacher-Nadelle Brief and Cooper Case (both appearing in American Journal of Drug Law Policy). Hans F. Paulson PhD CHRC Health Law Policy Swedish Institute of Public Health and the European Project on Psychoactive Addictions Information Security said in an article that It does not appear that the marijuana industry is engaging in an effective public information campaign.
Based on the survey findings and the answers from respondents the general public would view the joint statement by the U. S. Attorney James Rodrick and DEA agents after reviewing it as false statement of the truth.
The studys limitation is that the words research in the sense of a scientific statement of the truth was not explicitly provided in the case filed by the DEAs Office of Public Affairs.
Next the California Joint Commission (CJC) will hold an open meeting on January 12 2020 at 7:00 p. m. to consider whether to revoke the provisional injunction (PDF) that was previously issued suspending the sale of 60000 pounds of medical cannabis. However the meeting which has already been canceled will take place on January 15 2020 at 10:00 p. m. in Room 164s M 8404 S San Diego.